Merck KGaA (OTCMKTS:MKKGY) Reaches New 12-Month High – Should You Buy?

Merck KGaA (OTCMKTS:MKKGY – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $33.8620 and last traded at $33.82, with a volume of 7749 shares traded. The stock had previously closed at $32.96.

Analysts Set New Price Targets

MKKGY has been the subject of a number of analyst reports. Jefferies Financial Group initiated coverage on shares of Merck KGaA in a research note on Tuesday, May 26th. They set a “hold” rating for the company. Sanford C. Bernstein raised shares of Merck KGaA to a “hold” rating in a research report on Thursday, March 19th. Five research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has an average rating of “Hold”.

Get Merck KGaA alerts:

Get Our Latest Stock Analysis on MKKGY

Merck KGaA Price Performance

The stock has a market capitalization of $21.81 billion, a PE ratio of 15.00, a PEG ratio of 2.97 and a beta of 1.00. The company has a quick ratio of 1.00, a current ratio of 1.51 and a debt-to-equity ratio of 0.36. The firm’s fifty day moving average price is $29.76 and its two-hundred day moving average price is $28.63.

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.14. The company had revenue of $6.03 billion during the quarter, compared to analysts’ expectations of $5.93 billion. Merck KGaA had a return on equity of 8.79% and a net margin of 12.07%. On average, equities analysts predict that Merck KGaA will post 1.87 earnings per share for the current year.

About Merck KGaA

(Get Free Report)

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.

Read More

• Five stocks we like better than Merck KGaA
• AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
• Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
• Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
• Why Kroger’s Giant Eagle Deal Could Change Everything

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.